Aligos Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Aligos Therapeutics, Inc. has filed 345 SEC EDGAR filings since 16 Jan 2020

SEC filing history

Showing 176-200 of 345 matching filings.

Per page
25
Current page
8
4

4 filing

Filing date
21 Jul 2023
Reporting date
20 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jul 2023
Reporting date
20 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jul 2023
Reporting date
20 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jul 2023
Reporting date
20 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jul 2023
Reporting date
20 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFR14A File 001-39617

DEFR14A

Filing date
02 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-39617

ARS

Filing date
28 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39617

DEFA14A

Filing date
28 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39617

DEF 14A

Filing date
28 Apr 2023
Reporting date
20 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Mar 2023
Reporting date
15 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-270417

S-8

Filing date
09 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91770

ALIGOS THERAPEUTICS, INC.

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91770

AMENDMENT NO. 1

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91770

SC 13G/A filing

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91770

JHG PLC OWNS <5%

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91770

SC 13G/A

Filing date
08 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .